Glioblastoma (GBM) is an aggressive central nervous system cancer with a dismal
prognosis. The standard of care involves surgical resection followed by radiotherapy and …

Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

Glioblastoma (GBM) is an invasive cancer with high mortality in central nervous system.
Resistance to temozolomide (TMZ) and immunosuppressive microenvironment lead to low …

For decades, research in cancer biology has been focused on the protein-coding fraction of
the human genome. However, with the discovery of non-coding RNAs (ncRNAs), it has …

In the past decades, the striking development of cationic polypeptides and cell-penetrating
peptides (CPPs) tailored for small interfering RNA (siRNA) delivery has been fuelled by the …

Cancer still ranks as one of the top causes of morbidity and mortality despite recent
improvements in standard chemotherapy, radiotherapy, and surgery. This underlines some …

Brain tumor represents the most lethal form of cancer with the highest mortality and morbidity
rates irrespective of age and sex. Advancements in macromolecule-based therapy (such as …

In spite of established evidence of the synergistic combination of hydrophobic anticancer
molecule and microRNA for breast cancer treatment, their in vivo delivery has not been …

Glioblastoma multiforme (GBM) is an aggressive brain cancer showing poor prognosis.
Currently, treatment methods of GBM are limited with adverse outcomes and low survival …

Single chemotherapy often causes severe adverse effects and drug resistance to limit
therapeutic efficacy. As a noninvasive approach, photothermal therapy (PTT) represents an …